Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-138968
Filing Date
2016-08-11
Accepted
2016-08-11 16:02:18
Documents
55
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-11581_110q.htm 10-Q 944916
2 EX-31.1 a16-11581_1ex31d1.htm EX-31.1 12215
3 EX-31.2 a16-11581_1ex31d2.htm EX-31.2 12206
4 EX-32.1 a16-11581_1ex32d1.htm EX-32.1 6841
  Complete submission text file 0001104659-16-138968.txt   3980683

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20160630.xml EX-101.INS 731455
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20160630.xsd EX-101.SCH 31694
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20160630_cal.xml EX-101.CAL 44113
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20160630_lab.xml EX-101.LAB 330950
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20160630_pre.xml EX-101.PRE 246184
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20160630_def.xml EX-101.DEF 123835
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 161824557
SIC: 2834 Pharmaceutical Preparations